Department of Biomedicine🔬🧪
@biomedizin
As a joint venture of the University of Basel and the University Hospitals Basel, the Department of Biomedicine (DBM) brings together basic and clinical scientists to advance our understanding of health and disease.
New in @jamaneurology.com: Jens Kuhle from @biomedizin.unibas.ch, @unibas.ch and @dkf.unibas.ch together with other colleagues shows that the blood biomarker GFAP is associated with progression independent of relapses in multiple sclerosis and may complement NfL. Congratulations to the team! 👏👇
Dr. @mariuslange.bsky.social has been appointed Tenure-Track Assistant Professor of Systems Developmental Medicine. He combines computational biology & single-cell genomics to study how human tissues & organs develop, thereby advancing our understanding of early childhood development. 👇
🧠 Great news from the Molecular Neuroscience Lab! Professor Andreas Papassotiropoulos has been elected to the German National Academy of Sciences Leopoldina — one of the most prestigious scientific honors in the German-speaking world. Congratulations, Andreas! 🎉 biomedizin.unibas.ch/en/newsdetai...
Another ERC success for @biomedizin.unibas.ch: Judith Zaugg has been awarded an #ERCPoC Grant for HemaTrax, a project improving the prediction of blood toxicity in cancer therapy and drug development. It could support safer treatments and speed up the development of new therapies. 👍 @erc.europa.eu
🔬 Two new studies from the Pinschewer Lab at the DBM shed new light on antiviral immunity — from Lassa fever vaccination to B cell “attrition” in chronic infection. Congratulations to the team! 👏 Nature Communications: www.nature.com/articles/s41... PNAS: www.pnas.org/doi/10.1073/...
MISEV2023 sets key guidelines for EV research. With contributions from Edveena Hanser, Diego Kyburz, & an international consortium, the paper is now one of the top ten most-cited papers in JEV (Wiley, 2024). Congratulations to everyone involved. isevjournals.onlinelibrary.wiley.com/doi/10.1002/...
📺 TV tip The ZDF documentary “plan b: A fresh start for the knee” features research from the @biomedizin.unibas.ch , @unibas.ch, on cartilage regeneration using patients’ own cells. 📅 10 April, 19:40 (ARTE) and 12 April, 15:30 (ZDF) Also available online. Link in comments. @dkf.unibas.ch
Welcome on board @Frauke von Versen. We are happy to have you with us, and we wish you a great start! #Welcome2026 #welcometotheteam #welcomeonboard #TeamDBM @biomedizin.unibas.ch n.unibas.ch DBM News: 👉 biomedizin.unibas.ch/en/newsdetai...
Aβ and tau disrupt memory circuits in Alzheimer’s disease. New work from the @marcaurelbusche.bsky.social Lab at @biomedizin.unibas.ch .ch and @uclhresearch.bsky.social bsky.social links this to synaptic NMDA receptor hypofunction and shows recovery when both pathologies are reduced. 🔗See comments.
🔬 Science moves forward through collaboration! Researchers from @biomedizin.unibas.ch and the Department of Pharmaceutical Sciences (DPhW) came together for the DBM–DPhW Joint Meeting 2026 — a day of inspiring talks, exchange, and new connections across disciplines. 👏 #DBM #DPhW #LifeSciences
Today, we’ve officially launched the Xenium platform at @biomedizin.unibas.ch in collaboration with @bsse.ethz.ch. 🚀 A major step forward for spatial transcriptomics in Basel! 👉 biomedizin.unibas.ch/en/communica...
On Wednesday, we hosted the symposium, “Sex & Gender Differences in Medicine & Research,” with Athena’s Journey. Sex & gender influence disease risk, symptoms & outcomes - yet they are underrepresented in research. Integrating them isn’t optional. It’s essential. #SexandGender #ClosingTheGap #IDWGS
DBM Research Day 2026 has wrapped up! 🎉 There were great talks and lively discussions, as well as an excellent poster session showcasing emerging research across DBM. Thanks to everyone involved! See you in 2027! #DBMResearchDay #Science #TeamDBM @biomedizin.unibas.ch
How does aggressive AML originate? A new study shows that thrombopoietin can prime EVI1+ stem cells, making them more vulnerable to KMT2A fusion–driven leukemia, published in @natcomms.nature.com from the Schwaller lab @biomedizin.unibas.ch. 👉 www.nature.com/articles/s41... #AML @unibas.ch
How can a common virus contribute to a rare disease? A new @cp-immunity.bsky.social study from @biomedizin.unibas.ch links EBV to early MS-like lesion formation by showing how B cells can act at the very start of the disease process. 🔗 doi.org/10.1016/j.ce... @unibas.ch #EBV #MultipleSclerosis
Two back-to-back BJH papers from the XPAG-ITP trial! 🎉 ETB+dexamethasone showed longer response & less rescue therapy vs dex alone in ITP. Immune profiling reveals baseline TCR clonality predicts durable remission. 🔗 onlinelibrary.wiley.com/doi/10.1111/... #ITP #Hematology #TranslationalResearch
How can we tell whether an antibiotic eradicates an infection? Researchers from the @biomedizin.unibas.ch, at the @unibas.ch, present an antimicrobial single-cell microscopy-based method that measures antibiotic lethality in individual bacteria. 🔗 doi.org/10.1038/s415... @natmicrobiol.nature.com
As we wrap up 2025, we’re wishing you peaceful days filled with rest, joy, and good company. 🌟 Thank you for being part of our community this year. Happy Holidays and all the very best for 2026 — from all of us at the @ biomedizin.unibas.ch ! #HappyHolidays #NewYear2026 #Biomedicine #UniBasel
Our Tissue Engineering Lab has built the most advanced human bone marrow model! It supports blood cell formation, reduces the need for animal testing, and could one day aid drug testing and personalized cancer treatments. 👉 www.cell.com/cell-stem-ce... #TissueEngeneering #HumanBoneMarrowModel
New multicenter study from the RC2NB including members of the DBM shows granulocyte & astrocyte markers in CSF can clearly distinguish MOGAD and NMOSD from MS. 👉🏻 doi.org/10.1093/brai... #Neuroimmunology #MOGAD #NMOSD #MS #Biomarkers
New findings in Science Translational Medicine reveal distinct immune signatures in MOGAD, distinguishing it from MS and pointing toward disease-specific therapies. Kudos to all involved. 👉🏻 www.science.org/doi/10.1126/... #MOGAD #Neuroinflammation #MSResearch
Immune clues in tumors and blood predict who benefits from neoadjuvant chemoimmunotherapy in lung cancer. Congrats to the Zippelius Lab! www.nature.com/articles/s41... @nature.com #LungCancer #Immunotherapy #CancerResearch #Oncology #PrecisionMedicine
🚀 Breakthrough in #ProstateCancer research from @biomedizin.unibas.ch published in @cp-cellreports.bsky.social! Matrigel-free PDOs preserve patient-specific cell populations. New single-cell atlas (PPScA) maps heterogeneity + reveals pathways altered in vitro.
Researchers @biomedizin.unibas.ch developed cartilage implants from nasal septum cells, and showed that allowing them to mature for two weeks improved outcomes. 🔬Congratulations to all contributors. doi.org/10.1126/scit... #Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
New in Haematologica: Researchers at binderlab.bsky.social report a mutation-specific immunotherapy for high-risk CLL. A bispecific antibody (BiTE) redirects T cells to target IGLV3-21^R110+ leukemia cells—killing malignant cells while sparing healthy B cells. Link: doi.org/10.3324/haem...
Four DBM researchers at the University of Basel just secured ERC Starting Grants!🎉 A huge congratulations to Jean-Christophe Beltra, Mariana Borsa @nanaborsa.bsky.social , Magdalena Sznurkowska & Tobias Weiss. 🔗 Full news: biomedizin.unibas.ch/en/communica... @erc.europa.eu #ERCStG
🚀 Welcome Prof. Dr. Marc Aurel Busche @marcaurelbusche.bsky.social to the DBM, University of Basel! He’ll head the Brain Ageing & Neurodegeneration Lab, focusing on Alzheimer’s and brain circuit dysfunction. Read more: 🔗 biomedizin.unibas.ch/en/newsdetai...
🎊Cheers to 25 Years of Discovery @biomedizin.unibas.ch ! Since 2000, we’ve grown into one of Switzerland’s top translational research hubs — thanks to our brilliant teams & community. We celebrated with music, laughter, science & soul. Here’s to the next 25.💙 biomedizin.unibas.ch/en/newsdetai...
🏆 Dr. Laurentz Schuhknecht @zampierilab.bsky.social wins DBM Research Prize; Johanna Nimmerfroh (Läubli Lab) earns 1st Best Presentation Award at our Summer Symposium. Congratulations! 🎉 biomedizin.unibas.ch/en/communica... #DBMPrize #BestPresentationAward #ResearchExcellence
The 2025 DBM Summer Symposium is happening today! There will be a keynote by Prof. Mustafa Khammash @eth-bsse.bsky.social , 17 short talks, and the presentation of the DBM Research Prize 2024 and the Best Presentation Award 2025. 🧬🏆 Big thanks to all involved! #DBMSymposium2025 #Science #TeamDBM